Oncothyreon to Present at JMP Securities Healthcare Conference
SEATTLE, WA, July 5, 2012 /PRNewswire/ - Oncothyreon Inc. (Nasdaq: ONTY) announced today that management will be presenting at the Seventh Annual JMP Securities Healthcare Conference in New York on Thursday, July 12, 2012 at 2:30 p.m. Eastern.
A live and archived webcast of the presentation will be accessible by visiting the Oncothyreon website www.oncothyreon.com under the "News & Events" section.
Oncothyreon is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Oncothyreon's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients. For more information, visit www.oncothyreon.com.
SOURCE Oncothyreon Inc.